A Phase II Randomized, Placebo-Controlled, Double-Blind, Parallel Arms with Switchover, Pilot Study to Evlaluate the Efficacy and Safety of Intravenous Abatracept in Treamtne Resistant Nephrotic Syndrom (Focal Sebmental Glomerulosclerosis/Minimal Cha
Clinical Trial Grant
Administered By
Pediatrics, Nephrology
Awarded By
Bristol-Myers Squibb Company
Start Date
June 1, 2016
End Date
June 30, 2020
Administered By
Pediatrics, Nephrology
Awarded By
Bristol-Myers Squibb Company
Start Date
June 1, 2016
End Date
June 30, 2020